Human Metabolome Technologies, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3794530000
JPY
644.00
-16 (-2.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

  • INTEREST(HY) At JPY 1.18 MM has Grown at 10.52%
  • RAW MATERIAL COST(Y) Grown by 35% (YoY)
  • NET SALES(Q) Lowest at JPY 188.63 MM
2

With ROE of 14.19%, it has a very attractive valuation with a 2.30 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 4,381 Million (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.76

stock-summary
Return on Equity

11.58%

stock-summary
Price to Book

2.30

Revenue and Profits:
Net Sales:
189 Million
(Quarterly Results - Jun 2025)
Net Profit:
-48 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.09%
0%
-13.09%
6 Months
-19.8%
0%
-19.8%
1 Year
4.89%
0%
4.89%
2 Years
6.1%
0%
6.1%
3 Years
-7.74%
0%
-7.74%
4 Years
7.87%
0%
7.87%
5 Years
-15.04%
0%
-15.04%

Human Metabolome Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.86%
EBIT Growth (5y)
31.89%
EBIT to Interest (avg)
71.02
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.66
Tax Ratio
10.65%
Dividend Payout Ratio
34.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.30%
ROE (avg)
11.07%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.30
EV to EBIT
10.36
EV to EBITDA
7.95
EV to Capital Employed
5.25
EV to Sales
2.23
PEG Ratio
1.46
Dividend Yield
NA
ROCE (Latest)
50.66%
ROE (Latest)
14.19%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -18.04% vs 2.77% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -426.53% vs -74.30% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "188.60",
          "val2": "230.10",
          "chgp": "-18.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-75.80",
          "val2": "-9.10",
          "chgp": "-732.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.60",
          "chgp": "-16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "10.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-48.00",
          "val2": "14.70",
          "chgp": "-426.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-553.80%",
          "val2": "-138.10%",
          "chgp": "-41.57%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2025 is 8.12% vs 3.58% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2025 is 5.43% vs -14.91% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,455.00",
          "val2": "1,345.70",
          "chgp": "8.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "353.30",
          "val2": "306.50",
          "chgp": "15.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.50",
          "val2": "2.10",
          "chgp": "19.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "28.80",
          "val2": "20.50",
          "chgp": "40.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "256.40",
          "val2": "243.20",
          "chgp": "5.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "171.50%",
          "val2": "163.60%",
          "chgp": "0.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
188.60
230.10
-18.04%
Operating Profit (PBDIT) excl Other Income
-75.80
-9.10
-732.97%
Interest
0.50
0.60
-16.67%
Exceptional Items
10.70
0.00
Consolidate Net Profit
-48.00
14.70
-426.53%
Operating Profit Margin (Excl OI)
-553.80%
-138.10%
-41.57%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -18.04% vs 2.77% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -426.53% vs -74.30% in Jun 2024

Annual Results Snapshot (Consolidated) - Jun'25stock-summary
Jun'25
Jun'24
Change(%)
Net Sales
1,455.00
1,345.70
8.12%
Operating Profit (PBDIT) excl Other Income
353.30
306.50
15.27%
Interest
2.50
2.10
19.05%
Exceptional Items
28.80
20.50
40.49%
Consolidate Net Profit
256.40
243.20
5.43%
Operating Profit Margin (Excl OI)
171.50%
163.60%
0.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2025 is 8.12% vs 3.58% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2025 is 5.43% vs -14.91% in Jun 2024

stock-summaryCompany CV
About Human Metabolome Technologies, Inc. stock-summary
stock-summary
Human Metabolome Technologies, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available